LABMED 1999 Annual Report
I. Mission Statement and IntroductionLabrador-L Emergency Medical Assistance (LABMED) is a 501 (c)(3) nonprofit organization founded in 1996 to provide emergency monies to offset expenses incurred in the veterinary medical treatment of ill or injured Labrador Retrievers in a rescue situation. LABMED is a potential resource where funding medical treatment for an abandoned or rescued dog is unavailable or inadequate, owing to but not limited to: insufficient funds available through a local Labrador Retriever or general rescue organization for treatment of dogs, lack of a local Labrador Retriever or general rescue organization, or exhaustion of all other avenues of funding. What is LABMED? LABMED is an Internet based organization with international representation. By using the communication powers of the Internet, LABMED is able to intercede rapidly on the behalf of deserving Labrador Retrievers worldwide. The ultimate goal of LABMED is to help raise the quality of life and adoptability of rescued animals who are expected to regain good health and who display the positive temperament which so typifies the Labrador as a breed. LABMED provides these dogs with the opportunity to lead happy, healthy lives in stable loving homes. In addition, through its efforts and the example it sets, LABMED aims to stimulate a dialogue that will educate the general public about rescue animals and rescue organizations. LABMED is an organization that is meeting its challenges head on with professionalism and enthusiasm.
II. Funding ActivitiesIn addition to the usual high number of heartworm positive cases, LABMED funded a wide variety of medical emergencies. LABMED's Board approved funding for dogs that were hit by cars or otherwise injured, and dogs with health problems such as heart disease, cataracts, entropion syndrome and cancer. More unusual cases included treatment for an emaciated and pregnant young female whose litter was born in rescue, and the successful treatment of a dog that was bit by a rattlesnake. 1999 was another year of incredible growth for LABMED. During 1999, LABMED received 118 applications for assistance, of which 73 met our guidelines and received funding. Expenditures for these dogs totalled over $30,000 -- a 400% increase from 1998. Not all LABMED applications are approved. LABMED is careful to screen and double check each application making sure that guidelines are met. Furthermore, LABMED's Veterinary Advisory Board is consulted where there are questions about procedures and expected outcomes. III. Goals and ObjectiveObjective 1: Raise Public Awareness
Objective 2: Increase Revenues In 1999 LABMED was able to meet the increased demand for funds by continued development of funding sources. The following projects were part of that success.
In addition, the Board recognized the need for a stable funding base and formed the new Grants Committee. In 1999, this committee started their search for Grant Funding organizations, foundations and charities that might be sympathetic to LABMED's very unique niche. Objective 3: Board and Staff Development Board and volunteer development efforts continued with the appointment of a Volunteer coordinator and recruitment of new Board members. Three new Board members were added, and volunteers were recruited for a variety of tasks. IV. Financial Statement
LABMED's policy has been to ensure that direct donations are spent on funding dogs rather than on administrative costs. For the first time, in 1999, 100% of the Direct Donations Fund, including carryover from the previous year, was applied to dog funding. LABMED's Fundraising Committee's efforts funded administrative costs and also supplemented over $9000 in aide payments. 1996 Donation Income - $1,119 1999 Donation Income - $15,626 V. Directors, Officers, and Advisory Boards1999 LABMED Board of Directors Nancy Bard - Connecticut LABMED'S 1999 Officers This group assists LABMED by answering technical veterinary questions about a dog's condition, treatment and prognosis. Currently the following individuals serve on this panel: Adrienne Hudson-Willett, DVM |